Aripiprazole has been reported to suppress tumor growth by targeting Gαq and HTR1A, and therefore inhibiting PI3K/AKT/mTOR signaling.[24, 25] Indeed, mTOR inhibition by aripiprazole was also observed in this study, in which we identified LAMP2a as a novel target. Here, GNAQ is linked to neoplasm.